Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
43.5%
% of PPH's 26 holdings also in MEDX
33.3%
% of MEDX's 30 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.8% | 18.6% | 13.8% |
|
ABBVIE INC | 6.3% | 8.8% | 6.3% |
 |
NOVARTIS AG-ADR | 5.8% | 7.0% | 5.8% |
|
JOHNSON & JOHNSON | 7.2% | 5.3% | 5.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.1% | 5.6% | 5.1% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to MEDX
|
CENCORA INC | 5.8% |
|
MCKESSON CORP | 5.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 5.1% |
 |
SANOFI-AVENTIS-ADR | 5.0% |
|
ZOETIS INC | 4.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.3% |
|
VIATRIS, INC. | 2.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.1% |
|
JOHNSON & JOHNSON | 1.9% |
PPH Underweight Relative to MEDX
|
AMGEN INC | -6.2% |
|
ELI LILLY & CO | -4.9% |
|
ALNYLAM PHARMACEUTICALS INC | -4.5% |
 |
ALKERMES PLC | -4.1% |
|
REGENERON PHARMACEUTICALS | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.6% |
|
ABBVIE INC | -2.5% |
|
BIOGEN IDEC INC | -2.4% |
|
IONIS PHARMACEUTICALS, INC. | -2.3% |
|
BRISTOL-MYERS SQUIBB CO | -1.5% |